Pierre Larrieu

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Luc Pilotte, Pierre Larrieu, Vincent Stroobant et al. · Proceedings of the National Academy of Sciences · 2012 · 564 citations · Full text

Immunotoxicology, Immunology, Immunoediting +18

Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues

Ivan Théate, Nicolas van Baren, Luc Pilotte et al. · Cancer Immunology Research · 2014 · 358 citations

Immunology, Immunoediting, Pathology +21

Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators

Eduard Dolušić, Pierre Larrieu, Laurence Moineaux et al. · Journal of Medicinal Chemistry · 2011 · 180 citations · Full text

Immunology, Tryptophan Degradation, Cell Death +19

Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors

Ute F. Röhrig, Loay Awad, Aurélien Grosdidier et al. · Journal of Medicinal Chemistry · 2010 · 158 citations · Full text

Drug Target, Bioorganic Chemistry, Chemical Biology +16

A Spliced Antigenic Peptide Comprising a Single Spliced Amino Acid Is Produced in the Proteasome by Reverse Splicing of a Longer Peptide Fragment followed by Trimming

Alexandre Michaux, Pierre Larrieu, Vincent Stroobant et al. · The Journal of Immunology · 2014 · 74 citations

Peptide Engineering, Peptide Splicing, Immunology +17